TL;DR
This study investigates gender-specific differences in the electrophysiological characteristics and ablation outcomes of idiopathic right ventricular outflow tract-ventricular tachycardia (RVOT-VT). While subtle differences in electrical mapping were observed between genders, the success rates and recurrence of VT after catheter ablation were remarkably similar, suggesting that RVOT-VT is a generally treatable condition regardless of sex.
What Problem Does This Paper Address?
Idiopathic right ventricular outflow tract-ventricular tachycardia (RVOT-VT) is a common type of ventricular arrhythmia, particularly in younger individuals. While some ventricular arrhythmias show clear gender predilections (e.g., Brugada syndrome in males, Torsade de Pointes in females), the specific differences in RVOT-VT between men and women, particularly concerning its underlying electrical substrate and response to treatment, have not been thoroughly explored. This paper aims to fill this knowledge gap by comparing the electrophysiological characteristics and catheter ablation outcomes of male and female patients diagnosed with idiopathic RVOT-VT. Understanding these differences could lead to more personalized diagnostic and therapeutic approaches.
Methods
The study employed a retrospective analysis of 93 patients diagnosed with idiopathic RVOT-VT between 1998 and 2010. Standard electrophysiological studies (EPS) were performed after patients discontinued anti-arrhythmic medications. Key techniques included:
- Programmed Ventricular Electrical Stimulation: Used to induce VT and assess its characteristics.
- Electromechanical Mapping (NavX system): A 3D mapping system used to visualize endocardial activation sequences and identify the earliest endocardial activity and diastolic potentials during VT. This allowed for detailed mapping of the electrical substrate.
- Scar and Low Voltage Zone Analysis: Areas with reduced voltage (≤ 1.5 mV for low voltage zones, < 0.5 mV for scar zones) were identified, as these are often indicative of myocardial substrate abnormalities that can trigger VT.
- Catheter Ablation: Radiofrequency energy was delivered to ablate the VT origin.
- Statistical Analysis: Student's t-tests and Chi-square tests were used to compare continuous and categorical data, respectively, with a significance level of p < 0.05.
Datasets
The study utilized data from 93 patients (30 males, 63 females) diagnosed with idiopathic RVOT-VT at Taipei Veterans General Hospital. This dataset was collected retrospectively between 1998 and 2010. No new datasets or benchmarks were introduced.
Key Insights and Ideas
- Subtle Electrical Differences, Similar Outcomes: The most striking finding is that despite observable differences in the electrical mapping of the right ventricle (RV) between genders, the overall success and recurrence rates of catheter ablation for RVOT-VT were comparable. This suggests that while the underlying electrical "scarring" or substrate might manifest differently, it doesn't translate to different treatment efficacy.
- RVOT Free Wall Vulnerability: Females exhibited a higher prevalence of low voltage zones specifically in the RVOT free wall. This area is a common origin for RVOT-VT, hinting at a potential gender-specific predisposition in this region.
- Shorter QRS in Females: Female patients tended to have shorter QRS durations during VT, which is an interesting electrophysiological observation that warrants further investigation into its underlying mechanisms.
- RV Voltage Differences: Male patients generally had higher mean RV voltages compared to females. This could relate to differences in myocardial tissue composition or structure.
Key Results
- Demographics: No significant gender differences were found in age of onset, syncope, hypertension, diabetes, hyperlipidemia, or family history of ventricular arrhythmias.
- Electrocardiography: While QRS width was significantly longer in males (99.9 ± 19.4 ms) compared to females (88.4 ± 20.7 ms, p=0.02), other ECG parameters like atrial arrhythmias and QTc prolongation showed no significant gender differences.
- Electrophysiology & Mapping:
- Males had higher mean RV voltage (3.7 ± 0.9 mV vs. 3.0 ± 0.7 mV, p=0.03).
- Females had more low voltage zones in the RVOT free wall (27.0% vs. 6.7%, p=0.02).
- No significant gender differences were observed in scar zone distribution or other low voltage zone areas.
- Catheter Ablation Outcomes:
- Acute success rate was similar: 73.9% in males vs. 65.5% in females (p=0.47).
- VT recurrence rate was also similar: 26.1% in males vs. 27.6% in females (p=0.89).
- Repeat ablation rates were comparable.
Limitations and Future Work
- Echocardiography Limitation: The study acknowledges a limitation in that while some patients had RV regional dyskinesia on echocardiography, cardiac MRI was not performed to definitively rule out RV dysplasia. This is a common limitation in registry data.
- Registry Data: The reliance on registry data is noted as a universal limitation.
- Future Directions: The authors suggest that the observed gender differences in electroanatomic mapping, particularly the RVOT free wall low voltage zones and RV voltage, might reflect differences in ventricular remodeling. Further research into the mechanisms behind these differences, potentially involving sex hormones and ion channel expression, is warranted. The similar ablation outcomes suggest that while the substrate may differ, the therapeutic approach remains effective for both genders.
Summary updated